Mirati Therapeutics Inc

CUSIP: 60449T107 Class: COM

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2014
Shares 45,388 Value ($000) $841 Avg Close — Range —